Bessemer Group Inc Vanda Pharmaceuticals Inc. Transaction History

Bessemer Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$4.28 - $6.57 $3,073 - $4,717	718 New	718 $3,000
Q3 2020 Nov 12, 2020	SELL	$9.32 - $12.02 $458,544 - $591,384	-49,200 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$9.66 - $12.02 $475,272 - $591,384	49,200 New	49,200 $563,000
Q4 2019 Feb 04, 2020	SELL	$12.38 - $17.47 $928 - $1,310	-75 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$12.27 - $15.79 $478 - $615	39 Added 108.33%	75 $1,000
Q2 2019 Jul 19, 2019	BUY	$13.37 - $18.85 $481 - $678	36 New	36 $1,000

156

45M

167K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $269M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.